Jennifer Isacoff McNealey - 13 May 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Reporting relationship: Director
Issuer ticker: CDT
Reported as of: 13 May 2024
Net transaction value: -$358,150
SEC form: 4
Accepted by SEC: 15 May 2024, 16:30:47 UTC
Prior SEC filing: 05 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Isacoff McNealey

Key filing fact

Jennifer Isacoff McNealey filed Form 4 for CONDUIT PHARMACEUTICALS INC. (CDT) on 15 May 2024.

Key facts

This page summarizes Jennifer Isacoff McNealey's Form 4 filing for CONDUIT PHARMACEUTICALS INC. (CDT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 May 2024, 16:30.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: -$358,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDT transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $358,150
Shares: -65,000
Change %: -100%
Price: $5.51
Shares after: 0
Date: 13 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $5.51
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jennifer Isacoff McNealey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.

Footnote F2

The stock options were granted with a ten-year term and vest 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.